342 related articles for article (PubMed ID: 25534016)
1. Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome.
Belizna C
Autoimmun Rev; 2015 Apr; 14(4):358-62. PubMed ID: 25534016
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease.
Erkan D; Unlu O; Sciascia S; Belmont HM; Branch DW; Cuadrado MJ; Gonzalez E; Knight JS; Uthman I; Willis R; Zhang Z; Wahl D; Zuily S; Tektonidou MG;
Lupus; 2018 Mar; 27(3):399-406. PubMed ID: 28764618
[TBL] [Abstract][Full Text] [Related]
3. The effects of hydroxychloroquine and its promising use in refractory obstetric antiphospholipid syndrome.
Fierro JJ; Velásquez-Berrío M; Ospina A; Henning S; de Leeuw K; Cadavid J ÁP
Rheumatol Int; 2024 Feb; 44(2):223-234. PubMed ID: 37741812
[TBL] [Abstract][Full Text] [Related]
4. [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL].
Mekinian A; Vicaut E; Cohen J; Bornes M; Kayem G; Fain O
Gynecol Obstet Fertil Senol; 2018; 46(7-8):598-604. PubMed ID: 30041771
[TBL] [Abstract][Full Text] [Related]
5. Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.
Nuri E; Taraborelli M; Andreoli L; Tonello M; Gerosa M; Calligaro A; Argolini LM; Kumar R; Pengo V; Meroni PL; Ruffatti A; Tincani A
Immunol Res; 2017 Feb; 65(1):17-24. PubMed ID: 27406736
[TBL] [Abstract][Full Text] [Related]
6. The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study.
Kravvariti E; Koutsogianni A; Samoli E; Sfikakis PP; Tektonidou MG
Autoimmun Rev; 2020 Apr; 19(4):102491. PubMed ID: 32084592
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus.
Broder A; Putterman C
J Rheumatol; 2013 Jan; 40(1):30-3. PubMed ID: 22859353
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment.
Sciascia S; Branch DW; Levy RA; Middeldorp S; Pavord S; Roccatello D; Ruiz-Irastorza G; Tincani A; Khamashta M; Schreiber K; Hunt BJ
Thromb Haemost; 2016 Jan; 115(2):285-90. PubMed ID: 26421409
[TBL] [Abstract][Full Text] [Related]
9. [Hydroxychloroquine: a new therapeutic approach to the thrombotic manifestations of antiphospholipid syndrome].
Szymezak J; Ankri A; Fischer AM; Darnige L
Rev Med Interne; 2010 Dec; 31(12):854-7. PubMed ID: 20888088
[TBL] [Abstract][Full Text] [Related]
10. HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.
Belizna C; Pregnolato F; Abad S; Alijotas-Reig J; Amital H; Amoura Z; Andreoli L; Andres E; Aouba A; Apras Bilgen S; Arnaud L; Bienvenu B; Bitsadze V; Blanco P; Blank M; Borghi MO; Caligaro A; Candrea E; Canti V; Chiche L; Chretien JM; Cohen Tervaert JW; Damian L; Delross T; Dernis E; Devreese K; Djokovic A; Esteve-Valverde E; Favaro M; Fassot C; Ferrer-Oliveras R; Godon A; Hamidou M; Hasan M; Henrion D; Imbert B; Jeandel PY; Jeannin P; Jego P; Jourde-Chiche N; Khizroeva J; Lambotte O; Landron C; Latino JO; Lazaro E; de Leeuw K; Le Gallou T; Kiliç L; Limper M; Loufrani L; Lubin R; Magy-Bertrand N; Mahe G; Makatsariya A; Martin T; Muchardt C; Nagy G; Omarjee L; Van Paasen P; Pernod G; Perrinet F; Pïres Rosa G; Pistorius MA; Ruffatti A; Said F; Saulnier P; Sene D; Sentilhes L; Shovman O; Sibilia J; Sinescu C; Stanisavljevic N; Stojanovich L; Tam LS; Tincani A; Tollis F; Udry S; Ungeheuer MN; Versini M; Cervera R; Meroni PL
Autoimmun Rev; 2018 Dec; 17(12):1153-1168. PubMed ID: 30316994
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome.
Arachchillage DJ; Laffan M; Pericleous C
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674847
[TBL] [Abstract][Full Text] [Related]
12. Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients.
Petri M
Curr Rheumatol Rep; 2011 Feb; 13(1):77-80. PubMed ID: 20978875
[TBL] [Abstract][Full Text] [Related]
13. [Management of antiphospholipid syndrome].
Saadoun D; Piette JC; Wahl D; Costedoat-Chalumeau N
Rev Med Interne; 2012 Apr; 33(4):217-22. PubMed ID: 22360832
[TBL] [Abstract][Full Text] [Related]
14. Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?
Devaux CA; Camoin-Jau L; Mege JL; Raoult D
J Microbiol Immunol Infect; 2021 Feb; 54(1):37-45. PubMed ID: 33500211
[TBL] [Abstract][Full Text] [Related]
15. AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year Update.
Barbhaiya M; Andrade D; Erkan D;
Curr Rheumatol Rep; 2016 Oct; 18(10):64. PubMed ID: 27646150
[TBL] [Abstract][Full Text] [Related]
16. Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome.
Bertolaccini ML; Contento G; Lennen R; Sanna G; Blower PJ; Ma MT; Sunassee K; Girardi G
J Autoimmun; 2016 Dec; 75():30-38. PubMed ID: 27160365
[TBL] [Abstract][Full Text] [Related]
17. Prevention & treatment of obstetrical complications in APS: Is hydroxychloroquine the Holy Grail we are looking for?
Meroni PL
J Autoimmun; 2016 Dec; 75():1-5. PubMed ID: 27496152
[TBL] [Abstract][Full Text] [Related]
18. Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?
De Carolis S; Botta A; Salvi S; di Pasquo E; Del Sordo G; Garufi C; Lanzone A; De Carolis MP
Autoimmun Rev; 2015 Sep; 14(9):760-2. PubMed ID: 25936295
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis.
Arnaud L; Mathian A; Ruffatti A; Erkan D; Tektonidou M; Cervera R; Forastiero R; Pengo V; Lambert M; Martinez-Zamora MA; Balasch J; Zuily S; Wahl D; Amoura Z
Autoimmun Rev; 2014 Mar; 13(3):281-91. PubMed ID: 24189281
[TBL] [Abstract][Full Text] [Related]
20. The antiphospholipid syndrome in patients with systemic lupus erythematosus.
Pons-Estel GJ; Andreoli L; Scanzi F; Cervera R; Tincani A
J Autoimmun; 2017 Jan; 76():10-20. PubMed ID: 27776934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
